发明名称 |
Composition for preventing virus infection comprising poly-gamma-glutamic acid |
摘要 |
The present invention relates to a pharmaceutical composition for inhibiting or preventing viral infection, which comprises an effective dose of poly-gamma-glutamic acid (γ-PGA), and more particularly, to a pharmaceutical composition, a functional food, and a feedstuff additive capable of inhibiting viral infection and preventing viral diseases, which comprise poly-gamma-glutamic acid having an infection-inhibiting effect against viruses, such as an influenza virus, inducing respiratory infection or systemic infection, as an effective ingredient.;The composition containing poly-gamma-glutamic acid as an effective ingredient according to the present invention, is effective for use as an animal feedstuff additive or a pharmaceutical agent for preventing influenza virus infection and various viral diseases as well as a pharmaceutical composition and a functional food to promote human health. |
申请公布号 |
US9095605(B2) |
申请公布日期 |
2015.08.04 |
申请号 |
US201113234670 |
申请日期 |
2011.09.16 |
申请人 |
BIOLEADERS CORPORATION;KOREA RESEARCH INSTITUTE OF BIOSCIENCE AND BIOTECHNOLOGY |
发明人 |
Sung Moon-Hee;Kim Chul Joong;Poo Haryoung;Choi Young-Ki;Lee Il Han;Yoo Dai-Won |
分类号 |
A61K38/16;A61K31/785 |
主分类号 |
A61K38/16 |
代理机构 |
Moore & Van Allen, PLLC |
代理人 |
Fuierer Tristan A.;Moore & Van Allen, PLLC |
主权项 |
1. A method of treating diseases caused by virus infection induced by influenza virus comprising administering to a patient in need of such treatment a therapeutically or prophylactically effective dose of a pharmaceutical composition comprising 0.2 to 2.0 parts by weight of poly-gamma-glutamic acid based on 100 parts by weight of the composition, wherein the molecular weight of the poly-gamma-glutamic acid is about 3,000 to about 15,000 kDa. |
地址 |
KR |